beta-cryptoxanthin, ROTICHROM® dCHR, 2 mg, glass packaging

2-[(2-Chlorophenyl)thio]ethanol, 98.0%, 5g

(E)-2-((3-Nitropyridin-2-yl)methylene)hydrazinecarbothioamide, 95.0%, 100mg

2-Bromo-6-nitrobenzoic acid, 95.0%, 10g

Manganese(II) Bis(trifluoromethanesulfonyl)imide>97.0%(T)1g

5-methyl-1-(1,3-thiazol-2-yl)-1H-1,2,3-triazole-4-carboxylic acid, 95.0%, 250mg

METHYL 4-HYDROXY-2-NAPHTHOATE, 95.0%, 100mg

N-methoxy-N-methylpyridine-4-carboxamide, 95.0%, 100g

(R)-N-(2-oxo-2-(pyrrolidin-3-ylamino)ethyl)-3-(trifluoromethyl)benzamide, 98%, 1g

5,7-Di-tert-butyl-3-(3,4-dimethylphenyl)benzofuran-2(3H)-one, 97.0%, 25g

2,2-Dimethylbenzo[d][1,3]dioxole-5-carbaldehyde, 98%, 250mg

PYRIDAZINE, 3,6-DICHLORO-4-(1-METHYLETHYL)-, 95.0%, 250mg

BENZYL 7,7-DIFLUORO-1-METHYL-3-AZABICYCLO[4.1.0]HEPTANE-3-CARBOXYLATE, 90.0%, 2g